Form 4: Bicycle Therapeutics CEO Kevin Lee Sells Shares to Cover Tax Obligations

CEO of Bicycle Therapeutics, Kevin Lee, sold 3,158 ordinary shares to cover tax withholding obligations related to the vesting and settlement of Restricted Stock Units (RSUs).

Summary

• Kevin Lee, the CEO of Bicycle Therapeutics, sold 3,158 ordinary shares on April 3, 2024.
• The sale was executed to cover statutory tax withholding obligations associated with the vesting and settlement of RSUs.
• The shares were sold at a weighted average price of $23.81, with individual transactions ranging from $23.75 to $24.05.
• Following the transaction, Lee still beneficially owns 387,270 ordinary shares.

Sentiment

Score: 6

Explanation: Neutral sentiment as the transaction is a routine sale to cover tax obligations and doesn't reflect a significant change in the executive's holdings or outlook.

Industry Context

This is a routine transaction related to executive compensation and tax obligations. It is common for executives to sell shares to cover taxes upon the vesting of stock awards. It does not necessarily indicate a change in the executive's confidence in the company.

Stakeholder Impact

• The sale of shares may have a minor, temporary impact on the stock price, but is unlikely to have a significant long-term effect on shareholders.
• The transaction does not directly impact employees, customers, suppliers, or creditors.

Key Dates